Van Wart Harold
Insider CIK 1580680 · NONE President and CEO, Director · CNAT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-06-27 | 2019-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2017-06-22 | 2017-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-01-19 | 2017-01-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-01-04 | 2017-01-06 | 50,000 | — | $0 | 100,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2016-12-30 | 2017-01-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise deriv | 2016-10-27 | 2016-10-31 | 18,181 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise | 2016-10-27 | 2016-10-31 | 18,181 | $0.25 | $4.5K | 18,181 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2016-06-23 | 2016-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2016-01-26 | 2016-01-28 | 157,500 | — | $0 | 157,500 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2015-06-11 | 2015-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2015-05-18 | 2015-05-19 | 7,300 | $3.34 | $24.4K | 7,758 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2015-05-18 | 2015-05-19 | 100 | $3.29 | $329 | 7,858 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2015-05-18 | 2015-05-19 | 100 | $3.28 | $328 | 7,958 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2015-01-07 | 2015-01-08 | 180,000 | — | $0 | 180,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2014-06-19 | 2014-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2014-01-06 | 2014-01-08 | 141,290 | — | $0 | 141,290 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 5,535 | — | $0 | 5,535 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 1,493 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 1,493 | — | $0 | 1,493 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 5,974 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 5,974 | — | $0 | 5,974 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 5,535 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 1,257 | — | $0 | 1,257 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 1,257 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 6,212 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 6,212 | — | $0 | 6,212 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 9,745 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 358 | — | $0 | 358 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 358 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 95,997 | — | $0 | 95,997 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 9,745 | — | $0 | 9,745 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-10-31 | 2013-11-01 | 207,724 | — | $0 | 207,724 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2013-07-30 | 2013-08-01 | 30,000 | — | $0 | 30,000 | SEC↗ |